Tradestie Institutional Equity Comparison Engine
MTNB vs STTK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
STTK Overall Edge
STTK Captures Institutional Edge (3โ0 Pillars ยท 6โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shattuck Labs, Inc. Common Stock (STTK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus STTK at N/M Forward P/E and 0.0% operating margin (-66.6% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MTNB N/M vs STTK N/M Fwd P/E
Growth & Margin Winner
STTK
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs -66.6%
Momentum & Technical Winner
STTK
1Y -31.4% vs +126.4% ยท 52W Pos 22% vs 41%
Options & Structure Winner
STTK
UNCLASSIFIED (N/A IV) vs BREAKDOWN (10th %ile IV)
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
STTK
NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.55
+1.79% 1D
Market Cap
$459.8M
1M Return
-18.46%
1Y Return
+126.37%
Forward P/E
N/M
Unified AI Score
58.4 / 100
HOLD
Tech 82.0
Fund 50.0
Flow 63.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MTNB -31.35%
STTK +126.37%
Spread: +157.72 pp (STTK Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MTNB Revenue | STTK Revenue | MTNB Op. Margin | STTK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -12230.9% | N/A | MTNB |
| FY2019 | $0M | $10M | -21067.4% | -253.5% | STTK |
| FY2020 | $0M | $10M | -15288.4% | -371.8% | STTK |
| FY2021 | $0M | $30M | -74954.5% | -150.8% | STTK |
| FY2022 | $0M | $0M | -771.3% | -15848.0% | MTNB |
| FY2023 | $0M | $0M | -2168.4% | -5549.6% | MTNB |
| FY2024 | N/A | $10M | N/A | -1408.3% | STTK |
| FY2025 | N/A | $0M | N/A | -5150.8% | STTK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MTNB | STTK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $979,904 | $459.8M | Larger Scale | STTK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | -66.6% | Higher Growth | STTK |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -147.5% | -47.2% | Higher ROE | STTK |
| 52-Week Range Position Momentum | 22% ($0โ$3) | 41% ($2โ$8) | Stronger Trend | STTK |
| Beta / 30D Volatility Risk Regime | -7.20ฮฒ ยท 147% Vol | 1.46ฮฒ ยท 68% Vol | Lower Realized Risk | STTK |
| Unified Institutional Score Composite Signal | 54.6 / 100 (HOLD) | 58.4 / 100 (HOLD) | Higher Composite | STTK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MTNB vs STTK Buy Guide
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
STTK
BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MTNB nor STTK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.